Zobrazeno 1 - 4 of 4 pro vyhledávání: '"Annegrett Palavecino"'
1
Akademický článek
Effective Treatment against ESBL-Producing Klebsiella pneumoniae through Synergism of the Photodynamic Activity of Re (I) Compounds with Beta-Lactams
Autor: Iván A. González, Annegrett Palavecino, Constanza Núñez, Paulina Dreyse, Felipe Melo-González, Susan M. Bueno, Christian Erick Palavecino
Publikováno v: Pharmaceutics, Vol 13, Iss 11, p 1889 (2021)
Background: Extended-spectrum beta-lactamase (ESBL) and carbapenemase (KPC+) producing Klebsiella pneumoniae are multidrug-resistant bacteria (MDR) with the highest risk to human health. The significant reduction of new antibiotics development can be
Externí odkaz: https://doaj.org/article/a4441cf2c8494ccf9bdf02e9c30745ef
Zobrazit plný text záznamu
2
Akademický článek
Effective Photodynamic Therapy with Ir(III) for Virulent Clinical Isolates of Extended-Spectrum Beta-Lactamase Klebsiella pneumoniae
Autor: Constanza Núñez, Annegrett Palavecino, Iván A. González, Paulina Dreyse, Christian Erick Palavecino
Publikováno v: Pharmaceutics, Vol 13, Iss 5, p 603 (2021)
Background: The extended-spectrum beta-lactamase (ESBL) Klebsiella pneumoniae is one of the leading causes of health-associated infections (HAIs), whose antibiotic treatments have been severely reduced. Moreover, HAI bacteria may harbor pathogenic fa
Externí odkaz: https://doaj.org/article/852398b9a42b4793aef183dbca583aa1
Zobrazit plný text záznamu
3
Effective Treatment against ESBL-Producing Klebsiella pneumoniae through Synergism of the Photodynamic Activity of Re (I) Compounds with Beta-Lactams
Autor: Susan M. Bueno, Christian E. Palavecino, Annegrett Palavecino, Constanza Núñez, Paulina Dreyse, Ivan Gonzalez, Felipe Melo-González
Publikováno v: Pharmaceutics, Vol 13, Iss 1889, p 1889 (2021)
Pharmaceutics
Volume 13
Issue 11
Background: Extended-spectrum beta-lactamase (ESBL) and carbapenemase (KPC+) producing Klebsiella pneumoniae are multidrug-resistant bacteria (MDR) with the highest risk to human health. The significant reduction of new antibiotics development can be
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4df70232a1b399148df7d2383fb050fd
https://www.mdpi.com/1999-4923/13/11/1889
Zobrazit plný text záznamu
4
Effective Photodynamic Therapy with Ir(III) for Virulent Clinical Isolates of Extended-Spectrum Beta-Lactamase Klebsiella pneumoniae
Autor: Christian E. Palavecino, Constanza Núñez, Annegrett Palavecino, Ivan Gonzalez, Paulina Dreyse
Publikováno v: Pharmaceutics
Volume 13
Issue 5
Pharmaceutics, Vol 13, Iss 603, p 603 (2021)
Background: The extended-spectrum beta-lactamase (ESBL) Klebsiella pneumoniae is one of the leading causes of health-associated infections (HAIs), whose antibiotic treatments have been severely reduced. Moreover, HAI bacteria may harbor pathogenic fa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5b3adc8138a20e87a25a4e03f07a7df
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje